Dosage Form: topical powder
Nystatin Powder Description
Nystatin topical powder contains 100,000 USP nystatin units per gram dispersed in talc.
Nystatin Powder - Clinical Pharmacology
Fluocinolone Acetonide Topical Solution USP, 0.01% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. In hairy sites, the hair should be parted to allow direct contact with the lesion.
Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Indications and Usage for Nystatin Powder
Nystatin topical powder is not indicated for systemic, oral, intravaginal or ophthalmic use.
If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.
INFORMATION FOR PATIENT
- The patient should be instructed to use this medication as directed (including the replacement of missed doses). This medication is not for any disorder other than that for which it is prescribed.
- Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.
- If symptoms of irritation develop, the patient should be advised to notify the physician promptly.
Carcinogenesis & Mutagenesis & Impairment of Fertility
No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or its effects on male or female fertility.
Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether these preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nystatin topical powder should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.
Safety and effectiveness have been established in the pediatric population from birth to 16 years. (See DOSAGE AND ADMINISTRATION.)
Clinical studies with nystatin topical powder did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
The frequency of adverse events reported in patients using nystatin topical powder is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See PRECAUTIONS, General.)
Nystatin Powder Dosage and Administration
Adults and Pediatric Patients (Neonates and Older)
Apply to candidal lesions two or three times daily until healing is complete. For fungal infection of the feet caused by Candida species, the powder should be dusted on the feet, as well as, in all foot wear.
How is Nystatin Powder Supplied
15 g (NDC 43386-530-01)
30 g (NDC 43386-530-02)
56.7 g (NDC 43386-530-05)
60 g (NDC 43386-530-06)
Keep tightly closed.
Novel Laboratories, Inc.
Somerset, NJ 08873 USA
Lupin Pharmaceuticals, Inc.
Somerset, NJ 08873 USA
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
|Labeler - Lupin Pharmaceuticals,Inc. (089153071)|
|Registrant - Novel Laboratories, Inc. (793518643)|
|Novel Laboratories, Inc.||793518643||ANALYSIS(43386-530), MANUFACTURE(43386-530), PACK(43386-530)|
More about nystatin topical
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Compare Alternatives
- Pricing & Coupons
- En Español
- 16 Reviews – Add your own review/rating
- Drug class: topical antifungals
- Nystatin (AHFS Monograph)
- Nystatin Cream (FDA)
- Nystatin Ointment (FDA)
- Nystatin (Topical) (Wolters Kluwer)